Abstract
397 Can we use QT dispersion, signal-average ECG and heart rate variability indices for prediction of the outcome of antiarrhythmic drug therapy in patients with malignant ventricular tachyarrhythmias?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
